Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis

References

• D'Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 2004; 240:808-16; PMID:15492562; http://dx.doi.org/10.1097/01.sla.0000143245.28656.15
   PubMed Web of Science ®Google Scholar
• Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono H, Nagahori Y, Hosoi H, Takahashi M, Kito F et al. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study. Ann Surg Oncol 2006; 13:659-67; PMID:16538414; http://dx.doi.org/10.1245/ASO.2006.07.015
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 2010; 22:231-7; PMID:20144856; http://dx.doi.org/10.1016/j.coi.2010.01.009
   PubMed Web of Science ®Google Scholar
• Erez N, Coussens LM. Leukocytes as paracrine regulators of metastasis and determinants of organ-specific colonization. Int J Cancer J Int du Cancer 2011; 128:2536-44; PMID:21387299; http://dx.doi.org/10.1002/ijc.26032
   PubMed Web of Science ®Google Scholar
• Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960-4; PMID:17008531; http://dx.doi.org/10.1126/science.1129139
   PubMed Web of Science ®Google Scholar
• Sconocchia G, Zlobec I, Lugli A, Calabrese D, Iezzi G, Karamitopoulou E, Patsouris ES, Peros G, Horcic M, Tornillo L et al. Tumor infiltration by FcgammaRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma. Int J Cancer 2011; 128:2663-72; PMID:20715106; http://dx.doi.org/10.1002/ijc.25609
   PubMed Web of Science ®Google Scholar
• Galdiero MR, Bonavita E, Barajon I, Garlanda C, Mantovani A, Jaillon S. Tumor associated macrophages and neutrophils in cancer. Immunobiol 2013; 218:1402-10; PMID:23891329; http://dx.doi.org/10.1016/j.imbio.2013.06.003
   PubMed Web of Science ®Google Scholar
• Bosurgi L, Bernink JH, Delgado Cuevas V, Gagliani N, Joannas L, Schmid ET, Booth CJ, Ghosh S, Rothlin CV. Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer. Proc Natl Acad Sci U S A 2013; 110:13091-6; PMID:23878224; http://dx.doi.org/10.1073/pnas.1302507110
   PubMed Web of Science ®Google Scholar
• Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity 2014; 41:49-61; PMID:25035953; http://dx.doi.org/10.1016/j.immuni.2014.06.010
   PubMed Web of Science ®Google Scholar
• Kang R, Zhang Q, Zeh HJ, 3rd, Lotze MT, Tang D. HMGB1 in cancer: good, bad, or both? Clin Cancer Res 2013; 19:4046-57; PMID:23723299; http://dx.doi.org/10.1158/1078-0432.CCR-13-0495
   PubMed Web of Science ®Google Scholar
• Li W, Wu K, Zhao E, Shi L, Li R, Zhang P, Yin Y, Shuai X, Wang G, Tao K. HMGB1 recruits myeloid derived suppressor cells to promote peritoneal dissemination of colon cancer after resection. Biochem Biophys Res Commun 2013; 436:156-61; PMID:23707808; http://dx.doi.org/10.1016/j.bbrc.2013.04.109
   PubMed Web of Science ®Google Scholar
• Bianchi ME, Manfredi AA. How macrophages ring the inflammation alarm. Proc Natl Acad Sci U S A 2014; 111:2866-7; PMID:24532661; http://dx.doi.org/10.1073/pnas.1324285111
   PubMed Web of Science ®Google Scholar
• Lu B, Antoine DJ, Kwan K, Lundback P, Wahamaa H, Schierbeck H, Robinson M, Van Zoelen MA, Yang H, Li J et al. JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation. Proc Natl Acad Sci U S A 2014; 111:3068-73; PMID:24469805; http://dx.doi.org/10.1073/pnas.1316925111
   PubMed Web of Science ®Google Scholar
• Cottone L, Capobianco A, Gualteroni C, Perrotta C, Bianchi ME, Rovere-Querini P, Manfredi AA. 5-Fluorouracil causes leukocytes attraction in the peritoneal cavity by activating autophagy and HMGB1 release in colon carcinoma cells. Int J Cancer 2015; 136:1381-9; PMID:25098891; http://dx.doi.org/10.1002/ijc.29125
   PubMed Web of Science ®Google Scholar
• Capobianco A, Monno A, Cottone L, Venneri MA, Biziato D, Di Puppo F, Ferrari S, De Palma M, Manfredi AA, Rovere-Querini P. Proangiogenic Tie2(+) macrophages infiltrate human and murine endometriotic lesions and dictate their growth in a mouse model of the disease. Am J Pathol 2011; 179:2651-9; PMID:21924227; http://dx.doi.org/10.1016/j.ajpath.2011.07.029
   PubMed Web of Science ®Google Scholar
• Fong MY KS. Ovarian cancer mouse models: A summary of current models and their limitations. J Ovarian Res 2009; 2(1):12; PMID:19781107; http://dx.doi.org/10.1186/1757-2215-2-12
   PubMed Web of Science ®Google Scholar
• Colvin EK, Scarlett CJ. A historical perspective of pancreatic cancer mouse models. Semin Cell Dev Biol 2014; 27:96-105; PMID:24685616; http://dx.doi.org/10.1016/j.semcdb.2014.03.025
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Spiess P, Lafreniere R. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 1986; 233:1318-21; PMID:3489291; http://dx.doi.org/10.1126/science.3489291
   PubMed Web of Science ®Google Scholar
• Robinson-Smith TM, Isaacsohn I, Mercer CA, Zhou M, Van Rooijen N, Husseinzadeh N, McFarland-Mancini MM, Drew AF. Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice. Cancer Res 2007; 67:5708-16; PMID:17575137; http://dx.doi.org/10.1158/0008-5472.CAN-06-4375
   PubMed Web of Science ®Google Scholar
• Rei M, Goncalves-Sousa N, Lanca T, Thompson RG, Mensurado S, Balkwill FR, Kulbe H, Pennington DJ, Silva-Santos B. Murine CD27(-) Vgamma6(+) gammadelta T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages. Proc Natl Acad Sci U S A 2014; 111:E3562-70; PMID:25114209; http://dx.doi.org/10.1073/pnas.1403424111
   PubMed Web of Science ®Google Scholar
• Colvin EK. Tumor-associated macrophages contribute to tumor progression in ovarian cancer. Front Oncol 2014; 4:137; PMID:24936477; http://dx.doi.org/10.3389/fonc.2014.00137
   PubMedGoogle Scholar
• Bacci M, Capobianco A, Monno A, Cottone L, Di Puppo F, Camisa B, Mariani M, Brignole C, Ponzoni M, Ferrari S et al. Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J Pathol 2009; 175:547-56; PMID:19574425; http://dx.doi.org/10.2353/ajpath.2009.081011
   PubMed Web of Science ®Google Scholar
• Capobianco A, Rovere-Querini P. Endometriosis, a disease of the macrophage. Front Immunol 2013; 4:9; PMID:23372570; http://dx.doi.org/10.3389/fimmu.2013.00009
   PubMed Web of Science ®Google Scholar
• Segelman J, Granath F, Holm T, Machado M, Mahteme H, Martling A. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg 2012; 99:699-705; PMID:22287157; http://dx.doi.org/10.1002/bjs.8679
   PubMed Web of Science ®Google Scholar
• Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 2006; 243:212-22; PMID:16432354; http://dx.doi.org/10.1097/01.sla.0000197702.46394.16
   PubMed Web of Science ®Google Scholar
• Sloothaak DA, Mirck B, Punt CJ, Bemelman WA, van der Bilt JD, D'Hoore A, Tanis PJ. Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review. Br J Cancer 2014; 111:1112-21; PMID:25025964; http://dx.doi.org/10.1038/bjc.2014.369
   PubMed Web of Science ®Google Scholar
• Schiraldi M, Raucci A, Munoz LM, Livoti E, Celona B, Venereau E, Apuzzo T, De Marchis F, Pedotti M, Bachi A et al. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J Exp Med 2012; 209:551-63; PMID:22370717; http://dx.doi.org/10.1084/jem.20111739
   PubMed Web of Science ®Google Scholar
• Venereau E, Schiraldi M, Uguccioni M, Bianchi ME. HMGB1 and leukocyte migration during trauma and sterile inflammation. Mol Immunol 2013; 55:76-82; PMID:23207101; http://dx.doi.org/10.1016/j.molimm.2012.10.037
   PubMed Web of Science ®Google Scholar
• Yang H, Antoine DJ, Andersson U, Tracey KJ. The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukoc Biol 2013; 93:865-73; PMID:23446148; http://dx.doi.org/10.1189/jlb.1212662
   PubMed Web of Science ®Google Scholar
• Liu Y, Yan W, Tohme S, Chen M, Fu Y, Tian D, Lotze M, Tang D, Tsung A. Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll Like Receptor 9. J Hepatol 2015; 63(1):114-21; PMID:25681553; http://dx.doi.org/10.1016/j.jhep.2015.02.009
   PubMed Web of Science ®Google Scholar
• Yang H, Rivera Z, Jube S, Nasu M, Bertino P, Goparaju C, Franzoso G, Lotze MT, Krausz T et al. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc Natl Acad Sci U S A 2010; 107:12611-6; PMID:20616036; http://dx.doi.org/10.1073/pnas.1006542107
   PubMed Web of Science ®Google Scholar
• Qi F, Okimoto G, Jube S, Napolitano A, Pass HI, Laczko R, Demay RM, Khan G, Tiirikainen M, Rinaudo C et al. Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signaling. Am J Pathol 2013; 183:1654-66; PMID:24160326; http://dx.doi.org/10.1016/j.ajpath.2013.07.029
   PubMed Web of Science ®Google Scholar
• Jube S, Rivera ZS, Bianchi ME, Powers A, Wang E, Pagano I, Pass HI, Gaudino G, Carbone M, Yang H. Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. Cancer Res 2012; 72:3290-301; PMID:22552293; http://dx.doi.org/10.1158/0008-5472.CAN-11-3481
   PubMed Web of Science ®Google Scholar
• Ellerman JE, Brown CK, de Vera M, Zeh HJ, Billiar T, Rubartelli A, Lotze MT. Masquerader: high mobility group box-1 and cancer. Clin Cancer Res 2007; 13:2836-48; PMID:17504981; http://dx.doi.org/10.1158/1078-0432.CCR-06-1953
   PubMed Web of Science ®Google Scholar
• Campana L, Santarella F, Esposito A, Maugeri N, Rigamonti E, Monno A, Canu T, Del Maschio A, Bianchi ME, Manfredi AA et al. Leukocyte HMGB1 Is Required for Vessel Remodeling in Regenerating Muscles. J Immunol 2014; 192:5257-64; PMID:24752445; http://dx.doi.org/10.4049/jimmunol.1300938
   PubMed Web of Science ®Google Scholar
• Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B, Catalanotti F, Giazzon M, Dumitriu IE, Müller S, Iannacone M, Traversari C et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004; 5:825-30; PMID:15272298; http://dx.doi.org/10.1038/sj.embor.7400205
   PubMed Web of Science ®Google Scholar
• Amendola M, Passerini L, Pucci F, Gentner B, Bacchetta R, Naldini L. Regulated and multiple miRNA and siRNA delivery into primary cells by a lentiviral platform. Mol Ther 2009; 17:1039-52; PMID:19293777; http://dx.doi.org/10.1038/mt.2009.48
   PubMed Web of Science ®Google Scholar
• Cantore A, Ranzani M, Bartholomae CC, Volpin M, Valle PD, Sanvito F, Sergi LS, Gallina P, Benedicenti F, Bellinger D et al. Liver-directed lentiviral gene therapy in a dog model of hemophilia B. Sci Transl Med 2015; 7:277ra28; PMID:25739762; http://dx.doi.org/10.1126/scitranslmed.aaa1405
   PubMed Web of Science ®Google Scholar
• Manfredi AA, Capobianco A, Esposito A, De Cobelli F, Canu T, Monno A, Raucci A, Sanvito F, Doglioni C, Nawroth PP et al. Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. J Immunol 2008; 180:2270-5; PMID:18250435; http://dx.doi.org/10.4049/jimmunol.180.4.2270
   PubMed Web of Science ®Google Scholar
• Campana L, Bosurgi L, Bianchi ME, Manfredi AA, Rovere-Querini P. Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells. J Leukocyte Biol 2009; 86:609-15; PMID:19414537; http://dx.doi.org/10.1189/jlb.0908576
   PubMed Web of Science ®Google Scholar
• Cottone L, Valtorta S, Capobianco A, Belloli S, Rovere-Querini P, Fazio F, Manfredi AA, Moresco RM. Evaluation of the role of tumor-associated macrophages in an experimental model of peritoneal carcinomatosis using (18)F-FDG PET. J Nuclear Med 2011; 52:1770-7; PMID:22045707; http://dx.doi.org/10.2967/jnumed.111.089177
   PubMed Web of Science ®Google Scholar